This is the authors' abstract. We don't add key points for this paper.
Bisoprolol is safe and effective in the treatment of COPD, improving lung function and exercise performance in patients with COPD, and also reducing inflammatory markers in patients with COPD, and this effect is independent of the presence or absence of heart failure.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Feng et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: